RxDoctor Payments Data

Evelyn Johnson, MD

Family Medicine · Baxley, GANPI 1780645788

Payments from drug & device makers

$362in general payments, 2019–2025

Across 22 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$79
  • AbbVie$78
  • AstraZeneca$52
  • Xeris Pharmaceuticals, Inc.$49
  • Novo Nordisk$35
  • Sanofi-aventis U.S. LLC$17
  • plus $53 from 4 others

What the payments were for

  • Food & beverage$362100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$362 in reported general payments places this provider in the 40th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$23,012
Medicare patients
47
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl31$55,856
EliquisApixaban81$47,347
JanuviaSitagliptin Phosphate42$42,735
OzempicSemaglutide33$35,214
MounjaroTirzepatide24$25,569
MyrbetriqMirabegron71$23,756
XareltoRivaroxaban20$20,230
JanumetSitagliptin Phos/Metformin Hcl17$19,501
TradjentaLinagliptin38$16,490
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen491$14,263
LyricaPregabalin12$10,708
LinzessLinaclotide19$9,043
NamzaricMemantine Hcl/Donepezil Hcl12$7,117
SymbicortBudesonide/Formoterol Fumarate32$7,109
Humalog Kwikpen U-200Insulin Lispro17$6,963

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Linzess, Namzaric, Synthroid$78$73,24579 claims
PfizerEliquis, Lyrica$79$58,05693 claims
Novo NordiskOzempic$35$35,21433 claims
AstraZenecaSymbicort$52$7,10932 claims
Sanofi-aventis U.S. LLCLantus$17$1,41122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Baxley

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →